beta-thujaplicin has been researched along with Breast Neoplasms in 3 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
Breast Neoplasms: Tumors or cancer of the human BREAST.
Excerpt | Relevance | Reference |
---|---|---|
" In this study, we found that β-thujaplicin significantly suppressed the proliferation through arresting the cell cycle transition from G1 to S phase as well as inhibited the expression of cell cycle-related proteins, cyclin D1, and cyclin-dependent kinase 4 (CDK4) in MCF-7 and T47D luminal subtype breast cancer cells." | 3.81 | β-Thujaplicin modulates estrogen receptor signaling and inhibits proliferation of human breast cancer cells. ( Bao, C; Choi, HK; Kim, M; Kim, YS; Ko, J; Lee, HJ; Park, HC, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J | 1 |
Ko, J | 2 |
Kim, JT | 1 |
Cho, JS | 1 |
Qiu, S | 1 |
Kim, GD | 1 |
Auh, JH | 1 |
Lee, HJ | 2 |
Wang, WK | 1 |
Lin, ST | 1 |
Chang, WW | 1 |
Liu, LW | 1 |
Li, TY | 1 |
Kuo, CY | 1 |
Hsieh, JL | 1 |
Lee, CH | 1 |
Bao, C | 1 |
Park, HC | 1 |
Kim, M | 1 |
Choi, HK | 1 |
Kim, YS | 1 |
3 other studies available for beta-thujaplicin and Breast Neoplasms
Article | Year |
---|---|
β-Thujaplicin inhibits basal-like mammary tumor growth by regulating glycogen synthase kinase-3β/β-catenin signaling.
Topics: Animals; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chamaecyparis; Cyclin | 2019 |
Hinokitiol induces autophagy in murine breast and colorectal cancer cells.
Topics: Animals; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Colorectal Neoplas | 2016 |
β-Thujaplicin modulates estrogen receptor signaling and inhibits proliferation of human breast cancer cells.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Carcinogenesis; Cell Proliferation; Cyclin D1; Cyclin-Dep | 2015 |